FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014-2017

PLoS One. 2023 Feb 16;18(2):e0277976. doi: 10.1371/journal.pone.0277976. eCollection 2023.

Abstract

Background: Neisseria meningitidis (meningococcus) is the causative agent of invasive meningococcal disease (IMD). Meningococcus of serogroup B (MenB) is one of the main serogroup causing IMD. MenB strains may be prevented by meningococcal B vaccines. In particular, vaccines with Factor H-binding protein (FHbp), classified into two subfamilies (A or B) or in three variants (v1, v2 or v3), are those available. The objective of the study was to investigate the phylogenetic relationships of FHbp subfamilies A and B (variants v1, v2 or v3) genes and proteins, together with their evolution patterns and selective pressure.

Materials and methods: Overall, alignments of FHbp nucleotide and protein sequence from 155 MenB samples collected in different parts of Italy, from 2014 to 2017, were analyzed by ClustalW. JModeltest and the Smart Model Selection software were used for the statistical selection of the best-fit substitution models for nucleotide and protein alignments. Site-specific positive and negative selection were estimated through the HYPHY package. The phylogenetic signal was investigated with the likelihood mapping method. The Maximum Likelihood (ML) phylogenetic reconstructions were performed with Phyml.

Results: The phylogenic analysis identified different clusters within the FHbp subfamily A and B variants, confirming sequence diversity. The pattern of selective pressure in our study indicated that subfamily B FHbp sequences are subjected to greater variations and positive selective pressure respect to subfamily A, with 16 positively supported selected sites identified.

Conclusion: The study pointed out the need for continued genomic surveillance for meningococci to monitor selective pressure and amino acidic changes. Monitoring the genetic diversity and molecular evolution of FHbp variants may be useful to investigate genetic diversity which may emerge over time.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Bacterial / genetics
  • Bacterial Proteins / genetics
  • Carrier Proteins / genetics
  • Complement Factor H / genetics
  • Humans
  • Italy
  • Meningococcal Infections* / epidemiology
  • Meningococcal Infections* / genetics
  • Meningococcal Vaccines*
  • Neisseria meningitidis* / genetics
  • Neisseria meningitidis, Serogroup B* / genetics
  • Phylogeny
  • Serogroup

Substances

  • Bacterial Proteins
  • Antigens, Bacterial
  • Carrier Proteins
  • Complement Factor H
  • Meningococcal Vaccines

Grants and funding

The MenB sequences were obtained as previously reported [13; doi: 10.1371/journal.pone.0241793], thanks to the unconditional finantial support provided by Pfizer s.r.l within the frame of the project: W78 2017-2018 “Molecular Epidemiology of Invasive Meningococcal Diseases due to Neisseria meningitidis serogroup B in Italy”]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For the phylogenetic analyses, object of the present study, the authors received no specific funds.